PolyQ-expanded ataxin-3 levels can clearly discriminate ataxic and preataxic SCA3 subjects from healthy controls, indicating their potential to serve as potential target-engagement biomarkers. Here, ATXN3 is linked to Spinocerebellar ataxia type 3.